Blue Laser Fusion Completes Reverse Merger, Files 8‑K; Adopts 2026 Equity Plan

What Happened
Blue Laser Fusion, Inc. filed an 8‑K (Sept. 9, 2026) announcing the closing of a reverse merger with Private Blue Laser Fusion (effective Sept. 4, 2026), the related registered offering, management and board changes, and adoption of a 2026 Stock Incentive Plan. As a result the company has ceased to be a shell company and will replace its pre‑merger historical financials with Private Blue Laser Fusion’s financial statements in future SEC filings. The filing also summarizes executive compensation, employment offer letters for named officers (e.g., CEO Dr. Shuji Nakamura annual salary $108,000; VP Dr. Paul Rudy $180,000; GC Richard Ogawa $108,000; CAO Vanessa Truong $120,000), and director fee history (former director Nathan Pereira was paid $1,000/month).

Key Details

• Shares outstanding after closing: 7,904,099 (post‑Merger/Initial Offering); most shares are restricted and subject to Rule 144 limitations (12‑month restriction noted).
• Placement agent (Laidlaw) compensation: cash fees of 10% of gross proceeds from Laidlaw‑introduced investors and 5% from BLF‑introduced investors; non‑allocable expense reimbursements of 2%/1%; a $50,000 non‑refundable activation fee; placement agent warrants to buy 91,026 shares at $33.00 per share, exercisable for 7 years.
• Lucius Partners (pre‑Merger sole stockholder) retained 995,000 shares (~12.59%) after the transactions and could be seen as controlling ~13.59% including placement agent warrants.
• 2026 Stock Incentive Plan: initial share reserve depending on offering between ~2.08M and 2.26M shares plus 1,155,632 rollover options; plan allows options, SARs, RSUs, restricted stock, repricing without stockholder approval, and automatic annual increases (up to 4% of outstanding shares through 2036).

Why It Matters
This 8‑K documents a material change in the company’s structure and ownership: Blue Laser Fusion is no longer a shell company, has completed a registered offering, and adopted a broad equity incentive plan that can meaningfully increase dilution. Related‑party and placement agent arrangements (Laidlaw fees/warrants and Lucius Partners’ retained stake) are disclosed and could affect governance and control. Investors should note the post‑closing share count, founder/affiliate ownership levels, placement agent warrants, the 12‑month resale restrictions on shares, and the replacement of historical financials under reverse‑merger accounting when evaluating the company.